Radiation Protectors: the Unexpected Benefits

References

• Afzal S. M.J., Ainsworth E. J. Radioprotection of mouse colony forming units-spleen against heavy-charged particle damage by WR-2721. Radiat. Res. 1987; 109: 118–126
   PubMed Web of Science ®Google Scholar
• Akerfeldt S. Preparation and determination of sodium-hydrogen-s-(2-aminoethyl)phosphorothioate. Acta Chem. Scand 1959; 13: 1479–1480
   Google Scholar
• Akerfeldt S. Radioprotective effects of s-phosphorylated thiols. Acta Radiol. Ther. Phys. Biol 1963; 1: 465–470
   PubMed Web of Science ®Google Scholar
• Apffel C. A., Walker J. E., Issarescu S. Tumor rejection in experimental animals treated with radioprotective thiols. Cancer Res 1975; 35: 429–437
   PubMedGoogle Scholar
• Bacq Z. M., Herve, A. and others. Protection contre le rayonnement X par la beta-mercaptoéhylamine. Arch. Intern. Physiol 1951; 59: 442–447
   PubMed Web of Science ®Google Scholar
• Barendsen G. W., Walter H. M.D. Effect of different ionizing radiations on human cells in tissue culture. IV. Modification of radiation damage. Radiat. Res. 1964; 21: 314–329
   PubMed Web of Science ®Google Scholar
• Berry R. J. Interaction of drugs and radiation—promise or pitfall?. Clin. Radiol 1982; 33: 121–129
   PubMed Web of Science ®Google Scholar
• Biaglow J. E., Issels R. W., Gerweck, L. E. and others. Factors influencing the oxidation of cysteamine and other thiols: Implications for hyperthermic sensitization and radiation protection. Radiat. Res. 1984; 100: 298–312
   PubMed Web of Science ®Google Scholar
• Billen D. The effects of radioprotectors on DNA polymerase I-directed repair synthesis and DNA strand breaks in toluene-treated and X-irradiated Escherichia coli. Radiat. Res. 1983; 95: 158–164
   PubMed Web of Science ®Google Scholar
• Bird R. P. Cysteamine as a protective agent with high-LET radiations. Radiat. Res. 1980; 82: 290–296
   PubMed Web of Science ®Google Scholar
• Borek C., Troll W. Modifiers of free radicals inhibit in vitro the oncogenic actions of X-rays, bleomycin, and the tumor promotor 12—0-tetradecanoylphorbol-13-acetate. Proc. Natl. Acad. Sci. USA 1983; 80: 1304–1307
   PubMed Web of Science ®Google Scholar
• Bradley M. O., Kohn K. W. X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution. Nucleic Acid Res 1979; 7: 793–804
   PubMed Web of Science ®Google Scholar
• Brady L. W., Phillips T. L., Wasserman T. H. The potential for radiation sensitizers and radiation protectors combined wiht radiation therapy in gynecological cancer. Cancer 1981; 48: 650–657
   PubMed Web of Science ®Google Scholar
• Brown D. Q., Pittock J. W., Rubinstein J. S. Early results of the screening program for radioprotectors. Int. J. Radiat. Oncol. Biol. Phys 1982; 8: 565–570
   PubMed Web of Science ®Google Scholar
• Chemical Modifiers of Cancer Treatment, J. M. Brown. Pergamon Press Journals Ltd., New York 1986
   Google Scholar
• Brown J. M. Sensitizers and protectors in radiotherapy. Cancer 1985; 55: 2222–2228
   PubMed Web of Science ®Google Scholar
• Brown P. E. Mechanism of action of aminothiol radioprotectors. Nature 1967; 213: 363–364
   PubMed Web of Science ®Google Scholar
• Chak L. Y., Sikic B. I., Tucker M. H., Horns R. C., Cox R. S. Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung. J. Clin. Oncol 1984; 2: 385–390
   PubMed Web of Science ®Google Scholar
• Chan J. Y.H., Stout D. L., Becker F. F. Protective role of thiols in carcinogen-induced DNA damage in rat liver. Carcinogenesis 1986; 7: 1621–1624
   PubMed Web of Science ®Google Scholar
• Chapman J. D., Dugle D. L., Reuvers A. P., Gillespie C. J., Borsa J. Chemical radiosensitization studies with mammalian cells grown in vitro. Radiation Research, Nygaard, Adler, Sinclair. Academic Press, New York 1975; 752
   Google Scholar
• Clement J. J., Johnson R. K. Influence on WR-2721 on the efficacy of radiotherapy and chemotherapy of murine tumors. Int. J. Radiat. Oncol. Biol. Phys 1982; 8: 539–542
   PubMed Web of Science ®Google Scholar
• Connor A. M., Sigdestad C. P. Chemical protection against gastrointestinal radiation injury by WR 2822, WR 2823 or WR 109342 after 4 MeV x ray or fission neutron irradiation. Int. J. Radiat. Oncol. Biol. Phys 1982; 8: 547–551
   PubMed Web of Science ®Google Scholar
• Constine L. S., Zagars G., Rubin P., Kligerman M. M. Protection by WR-2721 of human bone marrow function following irradiation. Int. J. Radiat. Oncol. Biol. Phys 1986; 12: 1505–1508
   PubMed Web of Science ®Google Scholar
• Copland E. S. Free radicals in promotion—a chemical pathology study section report. Cancer Res 1983; 43: 5631–5637
   PubMed Web of Science ®Google Scholar
• Corn B. W., Liber H. L., Little J. B. Differential effects of radical scavengers on X-ray-induced mutation and cytotoxicity in human cells. Radiat. Res. 1987; 109: 100–108
   PubMed Web of Science ®Google Scholar
• Davidson D. E., Grenan M. M., Sweeney T. R. Biological characteristics of some improved radioprotectors. Radiation Sensitizers, L. Brady, 1980; 309–320, Cancer Management Vol. 5
   Google Scholar
• Denekamp J., Michael B. D., Rojas A., Stewart F. A. Radiopro-tection of mouse skin by WR-2721: The critical influence of oxygen tension. Int. J. Radiat. Oncol. Biol. Phys 1982; 8: 531–534
   PubMed Web of Science ®Google Scholar
• Dorr F. A., Coltman C. A. Second cancers following antineoplastic therapy. Curr. Probl. Cancer 1985; 9: 1–43
   PubMedGoogle Scholar
• Fowler J. F. Developing aspects of radiation oncology. Med. Phys 1981; 8: 427–434
   PubMed Web of Science ®Google Scholar
• Fry R. J. M. Radiation carcinogenesis: radioprotectors and photosensiti-zers. Radioprotectors and Anticarcinogens, O. Nygaard, M. G. Simic. Academic Press, New York 1983; 417–436
   Google Scholar
• Glick J. H., Glover D., Weiler C., Norfleet L., Yuhas J. M., Kligerman M. M. Phase I controlled trial of WR-2721 and cyclophosphamide. Int. J. Radiat. Oncol. Biol. Phys 1984; 10: 1777–1780
   PubMed Web of Science ®Google Scholar
• Glover D., Glick J. H., Weiler C., Yuhas J. M., Kligerman M. M. Phase I trials of WR-2721 and os-Platinum. Int. J. Radiat. Oncol. Biol. Phys 1984; 10: 1781–1784
   PubMed Web of Science ®Google Scholar
• Grdina D. J., Guilford W. H., Sigdestad C. P., Giometti C. S. Effects of radioprotectors on DNA damage and repair, proteins and cell-cycle progression. Pharmacol. Ther 1988a; 39: 133–137
   PubMed Web of Science ®Google Scholar
• Grdina D. J., Nagy B. The effect of S-[(aminopropyl)amino]ethan-thiol (WR-1065) on radiation-induced DNA damage and repair and cell progression in V79 cells. Br. J. Cancer 1986; 54: 933–941
   PubMed Web of Science ®Google Scholar
• Grdina D. J., Nagy B., Hill C. K., Sigdestad C. P. Protection against radiation-induced mutagenesis in V79 cells by 2-[(aminopropyl)a-mino]ethanethiol under conditions of acute hypoxia. Radiat. Res. 1989; 117, in press
   Web of Science ®Google Scholar
• Grdina D. J., Nagy B., Hill C. K., Wells R. L., Peraino C. The radioprotector WR-1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis 1985a; 6: 929–931
   PubMed Web of Science ®Google Scholar
• Grdina D. J., Nagy B., Sigdestad C. P. Radioprotectors in treatment therapy to reduce risk in secondary tumor induction. Pharmacol. Ther 1988b; 37: 21–25
   Google Scholar
• Grdina D. J., Peraino C., Carnes B. A., Hill C. K. Protective effect of S-2-(3-aminopropylamino)ethyl phosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation wihtin one day after birth. Cancer Res 1985b; 45: 5379–5381
   PubMed Web of Science ®Google Scholar
• Greenstock C. L. Redox process in radiation biology and cancer. Radiat. Res. 1981; 86: 196–211
   PubMed Web of Science ®Google Scholar
• Gupta R., Devi P. U. Protection of mouse chromosomes against whole-body gamma irradiation by SH-compounds. Br. J. Radiol 1986; 59: 625–627
   PubMed Web of Science ®Google Scholar
• Harman D. Chemical protection against aging. Agents and Actions 1969; 1: 3–8
   PubMedGoogle Scholar
• Harris J. W. Mammalian cell studies with diamide. Pharmacol. Ther 1979; 7: 375–391
   PubMed Web of Science ®Google Scholar
• Harris J. W., Phillips T. L. Radiobiological and biochemical studies of thiophosphate radio-protective compounds related to cysteamine. Radiat. Res. 1971; 46: 362–379
   PubMed Web of Science ®Google Scholar
• Hill C. K., Nagy B., Peraino C., Grdina D. J. WR-1065 is antineoplastic and anti-mutagenic when given during Co-gamma ray irradiation. Carcinogenesis 1986; 7: 665–668
   PubMed Web of Science ®Google Scholar
• Hollander C. F. Functional and cellular aspects of organ ageing. Exp. Geront 1970; 5: 313–321
   PubMed Web of Science ®Google Scholar
• Huber R., Teichman B. Is there any experimental evidence for the application of radioprotective substances in radiation therapy? (in German). Arch. Geschwulstforsch 1971; 37: 213–245
   PubMedGoogle Scholar
• Jacobs A. D., Gale R. P. Acute myelogenous leukemia following radiation and chemotherapy for osteogenic sarcoma. Cancer Treat. Rep. 1984; 68: 901–911
   PubMedGoogle Scholar
• Jordan S. W., Yuhas J. M., Glick J. Modulation of cis-platinum renal toxicity by the radioprotective agent WR-2721. Exp. Molec. Pathol 1982; 36: 297–305
   PubMed Web of Science ®Google Scholar
• Kennedy A. R., Troll W., Little J. B. Role of free radicals in the initiation and promotion of radiation transformation in vitro. Carcinogenesis 1984; 5: 1213–1218
   PubMed Web of Science ®Google Scholar
• Kensler T. W., Taffe B. G. Free radicals in tumor promotion. Adv. Free Radical Biol. Med. 1986; 2: 347–387
   Web of Science ®Google Scholar
• Kim J. H., Chu F. C. Chemical radiation sensitizers and protectors: recent developments. Clin. Bull 1981; 11: 5–11
   PubMedGoogle Scholar
• Kligerman M. M. Pions, protectors. Examples of a vigorous decade of radiotherapy. Am. J. Clin. Oncol 1982; 5: 101–113
   PubMed Web of Science ®Google Scholar
• Kligerman M. M., Glover D. J., Turrisi A. T., Norfleet, A. L., and others and others. Toxicity of WR-2721 administered in single and multiple doses. Int. J. Radiat. Oncol. Biol. Phys 1984a; 10: 1773–1776
   PubMed Web of Science ®Google Scholar
• Kligerman M. M., Shaw M. T., Slavik M., Yuhas J. M. Phase I clinical studies with WR-2721. Cancer Clin. Trials 1984b; 3: 217–221
   Google Scholar
• Kohn K. W. DNA as a target in cancer chemotherapy: Measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens. Methods Cancer Res 1979; 16: 291–345
   Google Scholar
• Lacassagne A. Chute de la sensibilite aux rayons X chex la souris nou-veau-nee en etat d'asphyxie. Compt. rend 1942; 215: 231–232
   Google Scholar
• Leonard A., Maisin J. R., Deknudt G. Effect of age and AET on life span of irradiated male and female rats. Strahlentherapie 1969; 137: 92–100
   PubMedGoogle Scholar
• Maisin J. R., Decleve A., Gerber G. B., Mattelin G., Lambiet-Collier M. Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation. II. Causes of death. Radiat. Res. 1978; 74: 415–435
   PubMed Web of Science ®Google Scholar
• Maisin J. R., Mattelin G., Lambiet-Collier M. Chemical protection against the long-term effects of a single whole-body exposure of mice to ionizing radiation. I. Life shortening. Radiat. Res. 1977; 71: 119–131
   PubMed Web of Science ®Google Scholar
• Marnett L. J. Peroxyl free radicals: potential mediators of tumor initiation and promotion. Carcinogenesis 1987; 8: 1365–1373
   PubMed Web of Science ®Google Scholar
• Marquardt H., Sapozink M. D., Zedeck M. S. Inhibition by cyste-amine-HCl of oncogenesis induced by DMBA without affecting toxicity. Cancer Res 1974; 34: 3387–3390
   PubMed Web of Science ®Google Scholar
• Meyn R. E., Jenkins W. T. Variation in normal and tumor tissue sensitivity of mice to ionizing radiation-induced DNA strand breaks in vivo. Cancer Res 1983; 43: 5668–5673
   PubMed Web of Science ®Google Scholar
• Milas L., Hunter N., Reid B. O., Thames H. D. Protective effects of S-2-(3-aminopropylamino)ethyl and phosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res 1982; 42: 1888–1897
   PubMedGoogle Scholar
• Milas L., Hunter N., Stephens C. L., Peters L. J. Inhibition of radiation carcinogenesis by S-2-(3-aminopropylamino)ethyl phosphorothioic acid. Cancer Res 1984; 44: 5567–5569
   PubMed Web of Science ®Google Scholar
• Murray D., Vanankeren S. C., Milas L., Meyn R. E. Radioprotective action of WR-1065 on radiation-induced DNA strand-breaks in cultured Chinese hamster ovary cells. Radiat. Res. 1988a; 113: 155–170
   PubMed Web of Science ®Google Scholar
• Murray D., Altschuler E. M., Kerr M. S., Vanankeren S. C., Meyn R. E., Milas L. Radioprotection of cultured Chinese hamster ovary cells by WR-255591. Int. J. Radiat. Biol 1988b; 54: 269–283
   PubMed Web of Science ®Google Scholar
• Nagy B., Dale P. J., Grdina D. J. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol. Cancer Res 1986; 46: 1132–1135
   PubMed Web of Science ®Google Scholar
• Nagy B., Grdina D. J. Protective effects of 2-[(aminopropyl)-amino]ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int. J. Radiat. Oncol. Biol. Phys 1986; 12: 1475–1478
   PubMed Web of Science ®Google Scholar
• Radioprotectors and Anti-carcinogens, O. F. Nygaard, M. G. Simic. Academic Press, New York 1983; 773
   Google Scholar
• Patt H. M. Protective mechanisms in ionizing radiation injury. Physiol. Rev. 1953; 33: 35–76
   PubMed Web of Science ®Google Scholar
• Patt H. M., Tyree E. B., Straube R. L., Smith D. E. Cysteine protection against X irradiation. Science 1949; 110: 213–214
   PubMed Web of Science ®Google Scholar
• Penn I. Second neoplasms following radiotherapy or chemotherapy for cancer. Am J. Clin. Oncol 1982; 5: 83–96
   PubMed Web of Science ®Google Scholar
• Phillips T. L. Chemical modification of radiation effects. Cancer 1977; 39: 987–999
   PubMed Web of Science ®Google Scholar
• Phillips T. L. Sensitizers and protectors in clinical oncology. Semin. Oncol 1981; 8: 65–82
   PubMed Web of Science ®Google Scholar
• Purdie J. W. A comparative study of the radioprotective effects of cyste-amine WR-2721 and WR-1065 in cultured human cells. Radiat. Res. 1979; 77: 303–311
   PubMed Web of Science ®Google Scholar
• Purdie J. W. Dephosphorylation of WR-2721 to WR-1065 in vitro and effect of WR-1065 and misonidazole in combination in irradiated cells. Radiation Sensitizers, L. W. Brady. Masson Publishing, New York 1980; 330–333
   Google Scholar
• Rasey J. S., Nelson, N.J., and others. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35-S-WR-2721 biodistribution. Radiat. Res. 1984; 97: 598–607
   PubMed Web of Science ®Google Scholar
• Reznikoff C. A., Brankow D. W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to post-confluent inhibition of division. Cancer Res 1973; 33: 3231–3238
   PubMed Web of Science ®Google Scholar
• Riklis E. DNA repair as a probe of radiosensitivity and radioprotection. Radioprotectors and Anticarcinogens, O. Nygaard, M. G. Simic. Academic Press, New York 1983; 363–380
   Google Scholar
• Rowley J. D., Golomb H. M., Vardinman J. W. Nonrandom chromosomal abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981; 58: 759–767
   PubMed Web of Science ®Google Scholar
• Schwartz J. L., Giovanazzi S. M., Karrison T., Jones C. A., Grdina D. J. 2[(Aminopropyl)amino] ethanethiol-mediated reduction in Co-60 gamma ray and fission spectrum neutron-induced chromosome damage in V79 cells. Radiat. Res. 1988; 113: 145–154
   PubMed Web of Science ®Google Scholar
• Shaw L. M., Turrisi A. T., Glover D. J., Bonner H. S., Norfleet A. L., Weiler C., Kligerman M. M. Human pharmacokinetics of WR-2721. Int. J. Radiat. Oncol. Biol. Phys 1986; 12: 1501–1504
   PubMed Web of Science ®Google Scholar
• Sigdestad C. P. Correlation of animal, crypt and stem cell survival in fission neutron irradiated mice: A chemical protection study. 1975; 101, National Technical Information Service document Acq. No. AD-A014 0675/7SL
   Google Scholar
• Sigdestad C. P., Connor A. M., Scott R. M. Chemical radiation protection of the intestinal epithelium by MEA and its thiophosphate derivative. Int. J. Radiat. Oncol. Biol. Phys 1975; 1: 53–60
   PubMed Web of Science ®Google Scholar
• Sigdestad C. P., Connor A. M., Scott R. M. The effect of WR-2721 on intestinal crypt survival. II Fission neutrons. Radiat. Res. 1976a; 65: 430–439
   PubMed Web of Science ®Google Scholar
• Sigdestad C. P., Connor A. M., Scott R. M. The effect of chemical protectors on the response of the intestine to X or fission neutron irradiation. Acta Radiol 1976b; 15: 401–409
   Web of Science ®Google Scholar
• Sigdestad C. P., Grdina D. J., Connor A. M., Hanson W. R. A comparison of radioprotection from three neutron sources and Co-60 by WR-2721 and WR-151327. Radiat. Res. 1986; 106: 224–233
   PubMed Web of Science ®Google Scholar
• Sigdestad C. P., Guilford W., Perrin J., Grdina D. J. Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors. Cell Tissue Kinet 1988; 21, in press
   PubMedGoogle Scholar
• Sigdestad C. P., Scott R. M., Hagemann R. F., Darden E. B. Intestinal crypt survival: The effect of cobalt-60, 250 kVcp x-rays and fission neutrons. Radiat. Res. 1972; 52: 168–178
   PubMed Web of Science ®Google Scholar
• Sigdestad C. P., Treacy S. H., Knapp L. A., Grdina D. J. The effect of 2-[(aminopropyl)amino]ethanthiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells. Br. J. Cancer 1987; 55: 477–482
   PubMed Web of Science ®Google Scholar
• Slaga, T.J., and others. Tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 1981; 213: 1023–1025
   PubMed Web of Science ®Google Scholar
• Sodicoff M., Ziskin M. C., Conger A. D. Effect of WR-2721 on fetal development in the rat. Radiat. Res. 1986; 107: 49–57
   PubMed Web of Science ®Google Scholar
• Steel L. K., Jacobs A. J., Giambarresi L. I., Jackson W. E. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327. Radiat. Res. 1987; 109: 469–478
   PubMed Web of Science ®Google Scholar
• Sweeney T. R. A Survey of Compounds from the Antiradiation Drug Development Program of the U.S. Army Medical Research and Development Command. Walter Reed Inst. Res., Washington, DC 1979
   Google Scholar
• Takeuchi I. K., Murakami U. The preventive influence of cyste-amine on teratogenic action of 5-azacytidine. Life Sci 1978; 23: 897–900
   PubMed Web of Science ®Google Scholar
• Tatsuta M., Iishi H., Yamamura H., Baba M., Taniguchi H. Inhibitory effect of prolonged administration of cysteamine on experimental carcinogenesis in rat stomach induced by N-methyl-N -nitro-Af-nitrosoguanidine. Radiat. Res., (in press)
   PubMedGoogle Scholar
• Troll W., Weisner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Annu. Res. Pharmacol. Toxicol 1985; 25: 509–528
   PubMed Web of Science ®Google Scholar
• Twentyman P. R. Modification of tumor and host response to cyclophosphamide by misonidazole and by WR-2721. Br. J. Cancer 1981; 43: 745–755
   PubMed Web of Science ®Google Scholar
• Utley J. F., Marlowe C., Waddell W. J. Distribution of S-labeled WR-2721 in normal and malignant tissues of the mouse. Radiat. Res. 1976; 68: 284–291
   PubMed Web of Science ®Google Scholar
• Valeriote F., Grates H. E. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells. Int. J. Radiat. Oncol. Biol. Phys 1984; 10: 1561–1564
   PubMed Web of Science ®Google Scholar
• Ward J. Chemical aspects of DNA radioprotection. Radioprotectors and Anticarcinogens, O. Nygaard, M. G. Simic. Academic Press, New York 1983; 73–85
   Google Scholar
• Washburn L. C., Carlton J. E., Hayes R. L., Yuhas J. M. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: Dependence on tumor type, drug and species. Radiat. Res. 1974; 59: 475–483
   PubMed Web of Science ®Google Scholar
• Weisberger A. S., Heinle R. W. The protective effect of cysteine on leukopenia induced by nitrogen mustard. J. Lab. Clin. Med. 1950; 36: 872–876
   PubMedGoogle Scholar
• Yuhas J. M. Differential protection of normal and malignant tissue against the cytotoxic effects of mechlorethamine. Cancer Treat. Rep. 1979; 63: 971–976
   PubMedGoogle Scholar
• Yuhas J. M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by WR-2721. Cancer Res 1980a; 40: 1519–1524
   PubMed Web of Science ®Google Scholar
• Yuhas J. M. A more general role for WR-2721 in cancer therapy. Br. J. Cancer 1980b; 41: 832–834
   PubMed Web of Science ®Google Scholar
• Yuhas J. M., Culo F. Selective inhibition of the nephrotoxicity of ras-platinum without altering its antitumor effectiveness. Cancer Treat. Rep. 1980; 64: 57–64
   PubMedGoogle Scholar
• Yuhas J. M., Davis, M.E., and others. Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity. Int. J. Radiat. Oncol. Biol. Phys 1982; 8: 51–522
   Google Scholar
• Yuhas J. M., Storer J. B. Differential chemoprotection of normal and malignant tissues. J. Natl. Cancer Inst 1969a; 42: 331–335
   PubMed Web of Science ®Google Scholar
• Yuhas J. M., Storer J. B. Chemoprotection against three modes of radiation death in the mouse. Int. J. Radiat. Biol 1969b; 15: 233–237
   Web of Science ®Google Scholar